Retour à la liste des essais cliniquesChildhood and adolescent cancers

HR-NBL2

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

Ouvert à Paris depuis le : 10/07/2020
Public cible : Child
Phase : Phase III

Description de l'essai

This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.

Url of the trial

Investigateur principal

GUDRUN SCHLEIERMACHER

Médecin

Contacter